脳神経外科手術のための　術後感染症予防実践マニュアル

出版社： メジカルビュー社
著者：
発行日： 2021-09-10
分野： 臨床医学：外科  >  脳神経外科学
ISBN： 9784758318570
電子書籍版： 2021-09-10 （第1版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

6,600 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

6,600 円(税込)

購入する

商品紹介

脳神経外科の各領域ごとに，術前から術中・術後までの感染症予防対策をトータルに解説。
『術後感染症予防抗菌薬適正使用のための実践ガイドライン』追補版（2020年）で追加された脳神経外科におけるガイドラインの基本的な考え方についても解説し，また万が一感染症が起きてしまったときの治療法も解説。
感染症対策・治療は手術全般にかかわる事項であり，術者のみならず手術にかかわるスタッフ全員が必携の1冊！

目次

  • I章　総論：脳神経外科手術における術後感染症
    　脳神経外科術後感染症について
    　一般的な予防法，問題点
    　抗菌薬投与の原則，消毒・滅菌の原則
    　術後感染予防抗菌薬ガイドライン

    II章　周術期における感染症予防対策
    　術前の感染症予防対策
    　手術室・術中の感染症予防対策
    　術後の感染症予防対策
    　術後感染症の治療：脳神経外科の術後感染症に対する治療とエビデンス
    　脳神経外科手術器械の滅菌法とプリオン病

    III章　脳神経外科各領域の感染症予防対策
    　脳神経外科全般
    　脊椎脊髄外科領域
    　小児神経外科領域
    　間脳下垂体腫瘍外科領域
    　頭部外傷・てんかん機能的脳神経外科領域
    　脳血管内治療

    IV章　抗菌薬について
    　脳神経外科でよく使う抗菌薬

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

I章 総論 : 脳神経外科手術における術後感染症

P.9 掲載の参考文献
1) Erman T, Demirhindi H, Gocer AI, et al. Risk factors for surgical site infections in neurosurgery patients with antibiotic prophylaxis. Surg Neurol. 2005;63 (2):107-12;discussion 112-3.
 
2) Barker FG 2nd. Efficacy of prophylactic antibiotic therapy in spinal surgery:A meta-analysis. Neurosurgery. 2002;51 (2):391-400;discussion 400-1.
 
3) Fang C, Zhu T, Zhang P, et al. Risk factors of neurosurgical site infection after craniotomy:A systematic review and meta-analysis. Am J Infect Control. 2017;45 (11):e123-34.
PubMed
4) Japan nosocomial infections surveillance. https://janis.mhlw.go.jp/index.asp.
 
5) 日本化学療法学会/日本外科感染症学会. 術後感染症予防抗菌薬ガイドライン作成委員会 編. 術後感染予防抗菌薬適正使用のための実践ガイドライン. Http://www.Chemotherapy.Or.Jp/guideline/jyutsugo_shiyou_jissen.Pdf
 
6) Bayston R, de Louvois J, Brown EM, et al. Use of antibiotics in penetrating craniocerebral injuries. "Infection in neurosurgery" working party of british society for antimicrobial chemotherapy. Lancet. 2000;355 (9217):1813-7.
PubMed
7) 細菌性髄膜炎診療ガイドライン作成委員会. 細菌性髄膜炎診療ガイドライン2014. 南江堂, 東京, 2014.
 
8) Sigurdardottir B, Bjornsson OM, Jonsdottir KE, et al. Acute bacterial meningitis in adults. A 20-year overview. Arch Intern Med. 1997;157 (4):425-30.
PubMed
9) van de Beek D, de Gans J, Spanjaard L, et al. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med. 2004;351 (18):1849-59.
PubMed
10) Tamune H, Takeya H, Suzuki W, et al. Absence of jolt accentuation of headache cannot accurately rule out meningitis in adults. Am J Emerg Med. 2013;31 (11):1601-4.
PubMed
11) Nakao JH, Jafri FN, Shah K, et al. Jolt accentuation of headache and other clinical signs:Poor predictors of meningitis in adults. Am J Emerg Med. 2014;32 (1):24-28.
PubMed
12) Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 infectious diseases society of america's clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017;64 (6):e34-65.
 
13) 高橋恵子, 石 晴, 森田昭彦, 他. 院内感染による細菌性髄膜炎本邦成人例における起因菌と転帰影響要因. 臨床神経学. 2013;53 (12):1461.
 
14) James HE, Walsh JW, Wilson HD, et al. Prospective randomized study of therapy in cerebrospinal fluid shunt infection. Neurosurgery. 1980;7 (5):459-63.
PubMed
15) Mallucci CL, Jenkinson MD, Conroy EJ, et al. Antibiotic or silver versus standard ventriculoperitoneal shunts (basics):A multicentre, single-blinded, randomised trial and economic evaluation. Lancet. 2019;394 (10208):1530-9.
 
16) 三竿慧祐, 松田真伍, 加藤文英, 他. 小児のシャント感染に対して抗菌薬含浸シャントチューブによるVPシャント術が奏功した一例. 島根県中病医誌. 2020;45:69-73.
 
P.15 掲載の参考文献
1) Steinsapir KD, Woodward JA. Chlorhexidine keratitis:Safety of chlorhexidine as a facial antiseptic. Dermatol Surg. 2017;43:1-6.
PubMed
2) Bicknell PG. Sensorineural deafness following myringoplasty operations. J Laryngol Otol. 1971;85:957-61.
PubMed
3) Singh S, Blakley B. Systematic review of ototoxic pre-surgical antiseptic preparations-what is the evidence? J Otolaryngol Head Neck Surg. 2018;47:18.
PubMed
4) Misteli H, Weber WP, Reck S, et al. Surgical glove perforation and the risk of surgical site infection. Arch Surg. 2009;144:553-8;discussion 558.
PubMed
5) Laine T, Aarnio P. How often does glove perforation occur in surgery? Comparison between single gloves and a double-gloving system. Am J Surg. 2001;181:564-6.
 
6) Caillot JL, Paparel P, Arnal E, et al. Anticipated detection of imminent surgeon-patient barrier breaches. A prospective randomized controlled trial using an indicator underglove system. World J Surg. 2006;30:134-8.
PubMed
7) Naver LP, Gottrup F. Incidence of glove perforations in gastrointestinal surgery and the protective effect of double gloves:A prospective, randomised controlled study. Eur J Surg. 2000;166:293-5.
PubMed
8) Aarnio P, Laine T. Glove perforation rate in vascular surgery-a comparison between single and double gloving. VASA. 2001;30:122-4.
PubMed
9) Makama JG, Okeme IM, Makama EJ, et al. Glove perforation rate in surgery:a randomized, controlled study to evaluate the efficacy of double gloving. Surg Infect (Larchmt). 2016;17:436-42.
 
10) 手術医療の実践ガイドライン(改訂版). 日本手術医学学会, 2013.
 
11) The APSIC Guidelines for The Prevention of Surgical Site Infections 2018 Asia Pacific Society of Infection Control (APSIC).
 
P.26 掲載の参考文献
1) 日本化学療法学会/日本外科感染症学会, 術後感染予防抗菌薬適正使用に関するガイドライン作成委員会 編. 術後感染予防抗菌薬適正使用のための実践ガイドライン. 日化療会誌. 2016;2:4-12.
 
2) 満田年宏, 他. Guideline for Hand Hygiene in Health-Care Settings医療現場における手指衛生のためのCDCガイドライン. 国際医学出版, 東京, 2003, p5-10.
 
3) Noble WC. Dispersal skin microorganisms. Br J Dermatol. 1975;93:477-85.
PubMed
4) Casewell M, Phillipis I. Hand as route of transmission for Klebsiella species. Br Med J. 1977;2:1315-7.
 
5) Pittet D, Dharan S, Touveneau S, et al. Bacterial contamination of the hands of hospital staff during routine patient care. Arch Intern Med. 1999;159:821-6.
PubMed
6) 中田精三. 手術部位感染(surgical site infection:SSI)防止. 手術医療の実践ガイドライン改訂委員会(編). 手術医療の実践ガイドライン. 日本手術医学会, 東京, 2013, p59-79.
 
7) 浅井忠雄, 田中 晃, 荒川圭三, 他. 耳鼻咽喉科治療前後での口腔・鼻腔細菌叢の検討. 耳鼻臨床. 1994;補70:41-8.
 
8) 日本環境感染学会ワクチン委員会. 破傷風トキソイド. 医療関係者のためのワクチンガイドライン 第2版 追補版. 環境感染誌. 2017;4:53-5.
 
9) 満田年宏, 他. Guideline for Hand Hygiene in Health-Care Settings医療現場における手指衛生のためのCDCガイドライン. 国際医学出版, 東京, 2003, p16-27.
 
P.35 掲載の参考文献
1) 術後感染予防抗菌薬適正使用のための実践ガイドライン(Summary)-日本化学療法学会(http://www.chemotherapy.or.jp/guideline/jyutsugo_shiyou_jissen.pdf)/日本外科感染症学会(http://www.gekakansen.jp/file/antimicrobial-guideline.pdf) accessed Mar 12, 2021.
 
2) 日本化学療法学会/日本外科感染症学会, 術後感染予防抗菌薬ガイドライン作成委員会 編. 術後感染予防抗菌薬適正使用のための実践ガイドライン(追補版). 日化療会誌. 2020;68:310-20.
 
3) Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm. 2013 (1);70:195-283.
 
4) 1-186 BenedettaGuidlinesF (who. int) accessed Mar 12, 2021.
 
5) O'Hara LM, Thom KA, Preas MA. Update to the Centers for Disease Control and Prevention and the Healthcare Infection Control Practices Advisory Committee Guideline for the Prevention of Surgical Site Infection (2017):A summary, review, and strategies for implementation. Am J Infect Control. 2018;46:602-9.
 
6) Ban KA, Minei JP, Laronga C, et al. American College of Surgeons and Surgical Infection Society:Surgical Site Infection Guidelines, 2016 Update. J Am Coll Surg. 2017;224:59-74.
PubMed

II章 周術期における感染症予防対策

P.48 掲載の参考文献
1) CDC. Guideline for the prevention of surgical site infection. 2017.
 
2) WHO. Global guidelines for the prevention of surgical site infection. 2016.
 
3) ACS & SIS. Surgical site infection guidelines, 2016 Update. J Am Coll Surg. 2017;224:59-74.
 
4) APSIC guidelines for the prevention of surgical site infections. Antimicrob Resist Infect Control. 2019;8:174.
PubMed
5) Weimann A, Braga M, Carli F, et al. ESPEN guideline:Clinical nutrition in surgery. Clin Nutr. 2017;36:623-50.
 
6) 日本静脈経腸栄養学会 編. 静脈経腸栄養ガイドライン 第3版. 照林社, 東京, 2013.
 
7) 日本麻酔科学会 編. 周術期禁煙ガイドライン. 2015.
 
8) 日本リウマチ学会編. 関節リウマチ(RA)に対するTNF阻害薬使用の手引き(2020年2月1日改訂版). 2020.
 
9) 日本化学療法学会, 日本感染症学 MRSA感染症治療ガイドライン作成委員会. II MRAの院内感染対策. MRSA感染症の治療ガイドライン 2019年改訂版. 2019, p14-6.
 
P.59 掲載の参考文献
1) Mangram AJ, Horan TC, Pearson ML, et al. Hospital Infection Control Practices Advisory Committee:Guideline for prevention of surgical site infection, 1999. Infection Control Hosp Epidemiol. 1999;20:247-80.
 
2) Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm. 2013;70:195-283.
 
3) Bayston R, de Louvois J, Brown EM, et al. Use of antibiotics in penetrating craniocerebral injuries. "Infection in Neurosurgery" Working Party of British Society for Antimicrobial Chemotherapy. Lancet. 2000;355:1813-7.
PubMed
4) Barker FG 2nd. Efficacy of prophylactic antibiotics for craniotomy:a meta-analysis. Neurosurgery. 1994;35:484-90.
PubMed
5) Barker FG 2nd. Efficacy of prophylactic antibiotics against meningitis after craniotomy:a meta-analysis. Neurosurgery. 2007;60:887-94.
PubMed
6) Liu W, Ni M, Zhang Y, et al. Antibiotic prophylaxis in craniotomy:a review. Neurosurg Rev. 2014;37:407-14.
PubMed
7) Liu W, Neidert MC, Groen RJM, et al. Third-generation cephalosporins as antibiotic prophylaxis in neurosurgery:what's the evidence? Clin Neurol Neurosurg. 2014;116:13-9.
PubMed
8) Sandra I, Craig A, Umsheid CA, et al. Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017. JAMA Surg. 2017;152 (8):784-91.
 
9) 日本化学療法学会/日本外科感染症学会, 術後感染予防抗菌薬ガイドライン作成委員会 編. 術後感染予防抗菌薬適正使用のための実践ガイドライン(追補版). 日化療会誌.:2020;68 (3):310-20.
 
10) Classen DC, Evans RS, Pestotnik SL, et al. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med. 1992;326:281-6.
PubMed
11) van Kasteren ME, Mannien J, Ott A, et al. Antibiotic prophylaxis and the risk of surgical site infections following total hip arthroplasty:timely administration is the most important factor. Clin Infect Dis. 2007;44:921-7.
PubMed
12) Steinberg JP, Braun BI, Hellinger WC, et al;Trial to Reduce Antimicrobial Prophylaxis Errors (TRAPE) Study Group. Timing of antimicrobial prophylaxis and the risk of surgical site infections:results from the Trial to Reduce Antimicrobial Prophylaxis Errors. Ann Surg. 2009;25:10-6.
 
13) Kyouichi N. Prevention of surgical site infection:important points from the Centers for Disease Control and Prevention 1999 and 2017 Guidline. Ped Cardi and Cardi Surg. 2019;35 (4):214-20.
 
14) 入江 伸, 寺川雅人, 石橋光治, 他. 健常成人男子におけるセファメジン注射用1gキットによるcefazolinの体内動態. 化学療法の領域. 1999;15:766-74.
 
15) 諸藤陽一, 石坂俊輔, 竹下朝規, 他. 脳神経外科手術の術後創感染に対する周術期予防的抗菌薬投与の意義. No Shinkei Geka. 2008;36 (9):769-74.
 
16) Ohge H, Takesue Y, Yokoyama Y, et al. Additional dose of cefazolin for intraoperative prophylaxis. Surg Today. 1999;29:1233-6.
PubMed
17) Forse RA, Karam B, MacLean LD, et al. Antibiotic prophylaxis for surgery in morbidly obese patients. Surgery. 1989;106:750-7.
PubMed
18) Hanssen AD, Osmon DR. The use of prophylactic antimicrobial agents during and after hip arthroplasty. Clin Orthop Relat Res. 1999;369:124-38.
PubMed
19) Knibbe CAJ, Brill MJE, van Rogen A, et al. Drug disposition in obesity:toward evidence-based dosing. Annu Rev Pharmacol Toxicol. 2015;55:149-67.
 
20) Bearden DT, Rodvold KA. Dosage adjustments for antibacterials in obese patients:applying clinical pharmacokinetics. Clin Pharmacokinet. 2000;38:415-26.
PubMed
21) Vance-Bryan K, Guay DR, Rodvold KA, et al. Effect of obesity on vancomycin pharmacokinetic parameters as determined by using a Bayesian forecasting technique. Antimicrob Agents Chemother. 1993;37:436-40.
PubMed
22) Hargrove R, Ridgeway S, Russell R, et al. Does pulse lavage reduce hip hemiarthroplasty infection rates? J Hosp Infect. 2006;62 (4):446-9.
PubMed
23) Nikfarjam M, Weinberg L, Fink MA, et al. Pressurized pulse irrigation with saline reduces surgical-site infections following major hepatobiliary and pancreatic surgery:randomized controlled trial. World J Surg. 2014;38 (2):447-55.
PubMed
24) Hanan H, Marja A, et al. Global Guidelines for The Prevention of Surgical Site Infection. World Health Organization. 2016, 4.18.
 
P.68 掲載の参考文献
1) Ireland S, Carlino K, Gould L, et al. Shampoo after craniotomy:a pilot study. Can J Neurosci Nurs. 2007;29 (1):14-9.
PubMed
2) 社本生衣, 小松万喜子. 入院患者の頭髪および頭皮のブドウ球菌の汚染状況と洗髪による汚染除去の効果. 愛知県立大学看護学部紀要. 2015;21:21-9.
 
3) Pfisterer W, Muhlbauer M, Czech T, et al. Early diagnosis of external ventricular drainage infection:results of a prospective study. J Neurol Neurosurg Psychiatry. 2003;74 (7):929-32.
PubMed
4) Fukunaga A, Naritaka H, Fukaya R, et al. Povidone-iodine ointment and gauze dressings associated with reduced catheter-related infection in seriously ill neurosurgical patients. Infect Control Hosp Epidemiol. 2004;25 (8):696-8.
PubMed
5) Zhou YJ, Wu JN, Chen LJ, et al. Comparison of infection rate with tunneled vs standard external ventricular drainage:A prospective, randomized controlled trial. Clin Neurol Neurosurg. 2019;184:105416.
PubMed
6) Park J, Choi YJ, Ohk B, et al. Cerebrospinal Fluid Leak at Percutaneous Exit of Ventricular Catheter as a Crucial Risk Factor for External Ventricular Drainage-Related Infection in Adult Neurosurgical Patients. World Neurosurg. 2018;109:e398-403.
 
7) Fried HI, Nathan BR, Rowe AS, et al. The Insertion and Management of External Ventricular Drains:An Evidence-Based Consensus Statement:A Statement for Healthcare Professionals from the Neurocritical Care Society. Neurocrit Care. 2016;24 (1):61-81.
PubMed
8) 手術医療の実践ガイドライン改訂委員会. 手術医療の実践ガイドライン(改訂第三版). 手術医学.2019;40 Supplement.
 
9) 日本化学療法学会/日本外科感染症学会 術後感染予防抗菌薬適正使用に関するガイドライン作成委員会 編. 術後感染予防抗菌薬適正使用のための実践ガイドライン(追補版). 日化療会誌. 2020;68 (3):310-20.
 
10) Larsson A, Engstrom M, Uusijarvi J, et al. Hyperbaric oxygen treatment of postoperative neurosurgical infections. Neurosurgery. 2002;50 (2):287-95.
PubMed
P.79 掲載の参考文献
1) Yasuhara T, Murai S, Mikuni N, et al. Japanese National Questionnaire Survey in 2018 on Complications Related to Cranial Implants in Neurosurgery. Neurol Med Chir (Tokyo). 2020;60 (7):337-50. doi:10.2176/nmc.oa.2020-0051. Epub 2020 Jun 12.PMID:32536658;PMCID:PMC7358783.
 
2) McClelland S III, Hall WA. Postoperative Central Nervous System Infection:Incidence and Associated Factors in 2111 Neurosurgical Procedures. Clin Infect Dis. 2007;45:55-9.
 
3) Nau R, Sorgel F, Eiffert H. Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections. Clin Microbiol Rev. 2010, 23 (4):858-83.
PubMed
4) Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004;39 (9):1267-84. doi:10.1086/425368. Epub 2004 Oct 6. PMID:15494903.
 
5) Tunkel AR, Hasbun R, Bhimraj A, et al. Infectious Diseases Society of America's Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis. Clin Infect Dis. 2017;64 (6):e34-65.
 
6) JAID/JSC感染症治療ガイド・ガイドライン作成委員会. JAID/JSC感染症治療ガイド2019.
 
7) Hussein K, Bitterman R, Shofty B, et al. Management of post-neurosurgical meningitis:narrative review. Clin Microbiol Infect. 2017;23 (9):621-8. doi:10.1016/j.cmi.2017.05.013.Epub 2017 May 18.PMID:28529027.
 
8) Cannon JP, Lee TA, Clark NM, et al. The risk of seizures among the carbapenems:a meta-analysis. J Antimicrob Chemother. 2014:69 (8):2043-55.
PubMed
P.85 掲載の参考文献
1) プリオン病のサーベイランスと感染予防に関する調査研究班・日本神経学会. プリオン病感染予防ガイドライン2020. http://prion.umin.jp/guideline/cjd_2020.pdf2020, 東京.
 
2) 太組一朗, 他. 器機の洗浄・滅菌. 松谷雅生, 他編. 脳神経外科 周術期管理のすべて 第5版. メジカルビュー社, 東京, 2019, p9-16.
 
3) https://www.jichi.ac.jp/dph/inprogress/prion/
 

III章 脳神経外科各領域の感染症予防対策

P.94 掲載の参考文献
1) Leaper DJ, Edmiston CE. World health organization:Global guidelines for the prevention of surgical site infection. J Hosp Infect. 2017;95(2):135-6.
PubMed
2) Berroos-Torres SI, Umscheid CA, Bratzler DW, et al. Centers for disease control and prevention guideline for the prevention of surgical site infection, 2017. JAMA Surg. 2017;152(8):784-91.
 
3) 術後感染症予防抗菌薬ガイドライン作成委員会 編. 術後感染予防抗菌薬適正使用のための実践ガイドライン(追補版). 日化療会誌. 2020;68(3):310-20.
 
4) Matsuda S, Ikawa F, Ohba H, et al. Questionnaire survey regarding prevention of surgical site infection after neurosurgery in japan:Focus on perioperative management and administration of surgical antibiotic prophylaxis. Neurol Med Chir(Tokyo). 2019;59(6):197-203.
PubMed
5) JAID/JSC感染症治療ガイド・ガイドライン作成委員会 編. JAID/JSC感染症治療ガイド2011. ライフサイエンス出版, 東京, 2011.
 
6) 日本化学療法学会/日本外科感染症学会. 術後感染症予防抗菌薬ガイドライン作成委員会 編. 術後感染予防抗菌薬適正使用のための実践ガイドライン. http://www.Chemotherapy.Or.Jp/guideline/jyutsugo_shiyou_jissen.pdf
 
7) 日本手術医学会. 手術医療の実践ガイドライン(改訂第三版). 手術医学. 2019;40(suppl):2p, 1-2, S1-195.
 
8) Barker FG 2nd. Efficacy of prophylactic antibiotics against meningitis after craniotomy:A meta-analysis. Neurosurgery. 2007;60(5):887-94;discussion 887-94.
 
9) Liu W, Ni M, Zhang Y, et al. Antibiotic prophylaxis in craniotomy:A review. Neurosurg Rev. 2014;37(3):407-14;discussion 414.
 
10) Liu W, Neidert MC, Groen RJ, et al. Third-generation cephalosporins as antibiotic prophylaxis in neurosurgery:What's the evidence? Clin Neurol Neurosurg. 2014;116:13-9.
PubMed
11) Blomstedt GC, Kytta J. Results of a randomized trial of vancomycin prophylaxis in craniotomy. J Neurosurg. 1988;69(2):216-20.
PubMed
P.107 掲載の参考文献
1) 高橋 淳, 池上章太, 二木俊匡, 他. 脊椎手術におけるSSI対策. 脊椎脊髄. 31, 2018;366-9.
 
2) Anderson PA, Savage JW, Vaccaro AR, et al. Prevention of surgical site infection in spinal surgery. Neurosurgery. 2017;suppl:80.
 
3) Yao R, Zhou H, Choma TJ, et al. Surgical site infection in spine surgery:Who is at risk? Global Spine J. 2018;5S-30S.
PubMed
4) 中原誠之, 伊東 学. 脊椎術後感染症の予防と対策. 脊椎脊髄. 2012;25:785-91.
 
5) Namba T, Ueno M, Inoue G, et al. Prediction tool for high risk of surgical site infection in spinal surgery. Infect Control Hosp Epidemiol. 2020;41:799-804.
PubMed
6) Ogihara S, Yamazaki T, Inanami H, et al. Risk factors for surgical site infection after lumbar laminectomy and/or discectomy for degenerative diseases in adults:A prospective multicenter surveillance study with registry of 4027 cases. PLoS One. 2018.
PubMed
7) Yasuhara T, Hishikawa T, Agari T, et al. Perioperative management center for neurosurgical patients. Neurol Med Chir (Tokyo). 2016;56:574-9.
PubMed
8) Yamamoto M, Hara K, Sugezawa K, et al. Disinfection with single or double usage of new antiseptic olanexidine gluconate in general surgery:a randomized study. Langenbecks Arch Surg. 2020;405:1183-9.
PubMed
9) Yamada K, Abe H, Higashikawa A, et al. Evidence-based care bundles for preventing surgical site infections in spinal instrumentation surgery. Spine. 2018;43:1765-73.
PubMed
10) Takeuchi M, Wakao N, Kamiya M, et al. A double-blind randomized controlled trial of the local application of vancomycin versus ampicillin powder into the operative field for thoracic and/or lumbar fusions. J Neurosurg Spine. 2018;29:553-9.
PubMed
11) Hellbusch LC, Helzer-Julin M, Doran SE, et al. Single-dose vs multiple-dose antibiotic prophylaxis in instrumented lumbar fusion? a prospective study. Surg Neurol. 2008;70:622-7.
PubMed
12) Long DR, Bryson-Cahn C, Pergamit R, et al. 2021 Young investigator award winner:Anatomic gradients in the microbiology of spinal fusion surgical site infection and resistance to surgical antimicrobial prophylaxis. Spine. 2021;46:143-51.
PubMed
13) El-Kadi M, Donovan E, Kerr L, et al. Risk factors for postoperative spinal infection:A retrospective analysis of 5065 cases. Surg Neurol Int. 2019;10:121.
PubMed
14) Fukuda H, Sato D, Iwamoto T, et al. Healthcare resources attributable to methicillin-resistant Staphylococcus aureus orthopedic surgical site infections. Sci Rep. 2020;10:17059.
PubMed
P.112 掲載の参考文献
1) Klimo P, Van Poppel M, Thompson CJ, et al. Pediatric hydrocephalus:systematic literature review and evidence-based guidelines. Part 6:Preioperative antibiotics for shunt surgery in children with hydrocephalus:a systematic review and meta-analysis. J Neurosurg Pediatr. 2014;(Suppl) 14:44-52.
 
2) Kestle JR, Holubkov R, Cochrane DD, et al. A new hydrocephalus clinical research network protocol to reduce cerebrospinal fluid shunt infection. J Neurosurg Pediatr. 2016;17:391-6.
 
3) Ratilal B, Costa J, Sampaio C. Antibiotic prophylaxis for surgical introduction of intracranial ventricular shunts. Cochrane Database Syst Rev. 2006;19 (3):CD005365. doi:10.1002/14651858.CD005365.pub2.
 
4) Klimo P, Thompson CJ, Baird LC, et al. Systematic literature review and evidence-based guidelines. Part 7:Antibiotic-impregnated shunt systems versus conventional shunts in children:a systematic review and meta-analysis. J Neurosurg Pediatr. 2014;(Suppl) 14:53-9.
 
5) Choux M, Genitori L, Lang D, et al. Shunt implantation:reducing the incidence of shunt infection. J Neurosurg. 1992;77(6):875-80.
PubMed
6) Rotim K, Miklic P, Paladino J, et al. Reducing the incidence of infection in pediatric cerebrospinal fluid shunt operations. Childs Nerv Syst. 1997;13:584-7.
PubMed
7) Tuli S, Drake JM, Lawless J, et al. Risk factors for repeated cerebrospinal shunt failures in pediatric patients with hydrocephalus. J Neurosurg. 2000;92:31-8.
 
8) Kulkarni AV, Drake JM, Lamberti-Pasculli M. Cerebrospinal fluid shunt infection:a prospective study of risk factors. J Neurosurg. 2001;94:195-201.
PubMed
9) Cochrane DD, Kestle JR. The influence of surgical operative experience on the duration of first ventriculoperitoenal shunt function and infection. Pediatr Neurosurg. 2003;38:295-301.
 
10) Smith ER, Butler WE, Barker FG 2nd. In-hospital mortality rates after ventriculoperitoneal shunt procedures in the United States, 1998 to 2000:relation to hospital and surgeon volume of care. J Neurosurg. 2004;100:90-7.
 
11) Sciubba DM, Stuart RM, McGirt MJ, et al. Effect of antibiotic-impregnated shunt catheters in decreasing the incidence of shunt infection in the treatment of hydrocephalus. J Neurosurg. 2005;103:131-6.
PubMed
12) Tulipan N, Cleves MA. Effect of an intraoperative double-gloving strategy on the incidence of cerebrospinal fluid shunt infection. J Neurosurg. 2006;104:5-8.
PubMed
P.124 掲載の参考文献
1) 日本化学療法学会/日本外科感染症学会, 術後感染予防抗菌薬ガイドライン作成委員会 編. 術後感染予防抗菌薬適正使用のための実践ガイドライン(追補版). 日化療会誌. 2020;68 (3);310-20.
 
2) Pagliano P, Caggiano C, Acione T, et al. Characteristics of meningitis following transsphenoidal endoscopic surgery:a case series and a systematic literature review. Infection. 2017;45 (6):841-8.
 
3) Lee CH, Ikeda AK, Patel S, et al. Risk factors for rhinosinusitis after endoscopic transsphenoidal adenomectomy. Am J Rhinol Allergy. 2021;35(3):348-52.
PubMed
4) Kuan EC, Rereddy SK, Patel NN, et al. Asymptomatic radiographic sinonasal inflammation does not affect pituitary surgery outcomes. Laryngoscope. 2019;129 (7):1545-8.
 
5) Kim DH, Hong YK, Jeun SS, et al. Is coincidental rhinosinusitis a predisposing factor for postoperative central nervous system infection after endoscopic endonasal transsphenoidal surgery? J Craniofac Surg. 2018;29 (3);e319-22.
PubMed
6) Bae WY, Kim SH, Kang MY, et al. Efficacy of controlling rhinosinusitis on the prevention of complications in pituitary surgery with transsphenoidal approach. Auris Nasus Larynx. 2014;41 (1):50-2.
PubMed
7) Arita K, Kurisu K, Tominaga A, et al. Thickening of sphenoid sinus mucosa during the acute stage of pituitary apoplexy-case report. J Neurosurg. 2001;95(5):897-901.
 
8) Shibao S, Toda M, Tomita T, et al. Analysis of the bacterial flora in the nasal cavity and the sphenoid sinus mucosa in patients operated on with an endoscopic endonasal transsphenoidal approach. Neurol Med Chir(Tokyo). 2014;54 (12):1009-13.
PubMed
9) Ceraudo M, Prior A, Balestrino A, et al. Ultra-short antibiotic prophylaxis guided by preoperative microbiological nasal swabs in endoscopic endonasal skull base surgery. Acta Neurochir (Wien). 2021;163 (2);369-82.
PubMed
10) Davis KA, Stewart JJ, Crouch HK, et al. Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin Infect Dis. 2004;39 (6):776-82.
PubMed
11) Little AS, White WL. Prophylactic antibiotic trends in transsphenoidal surgery for pituitary lesions. Pituitary. 2011;14 (2):99-104.
PubMed
12) Brown SM, Anand VK, Tabaee A, et al. Role of perioperative antibiotics in endoscopic skull base surgery. Laryngoscope. 2007;117 (9):1528-32.
PubMed
13) Korinek AM, Baugnon T, Golmard JL, et al. Risk factors for adult nosocomial meningitis after craniotomy:role of antibiotic prophylaxis. Neurosurgery. 2006;59(1):126-33.
 
14) Rudmik L, Soler ZM, Orlandi RR, et al. Early postoperative care following endoscopic sinus surgery:an evidence-based review with recommendations. Int Forum Allergy Rhinol. 2011;1 (6);417-30.
PubMed
15) 術後感染予防抗菌薬適正使用のための実践ガイドライン(Summary)-日本化学療法学会(http://www.chemotherapy.or.jp/guideline/jyutsugo_shiyou_jissen.pdf)/日本外科感染症学会(http://www.gekakansen.jp/file/antimicrobial-guideline.pdf)accessed Jul 13, 2021.
 
P.134 掲載の参考文献
1) Mann M, Wright CH, Jella T, et al. Cranial Surgical Site Infection Interventions and Prevention Bundles:A Systematic Review of the Literature. World Neurosurg. 2021;148:206-19.
PubMed
2) Owens WD, Felts JA, Spitznagel EL. ASA physical status classifications:a study of consistency of ratings. Anesthesiology. 1978;49 (4):239-43.
PubMed
3) Mu Y, Edwards JR, Horan TC, et al. Improving risk-adjusted measures of surgical site infection for the national healthcare safety network. Infect Control Hosp Epidemiol. 2011;32 (10):970-86.
PubMed
4) Parienti JJ, Thibon P, Heller R, et al. Hand-rubbing with an aqueous alcoholic solution vs traditional surgical hand-scrubbing and 30-day surgical site infection rates:a randomized equivalence study. JAMA. 2002;288 (6):722-7.
 
5) Constantoyannis C, Berk C, Honey CR, et al. Reducing hardware-related complications of deep brain stimulation. Can J Neurol Sci. 2005;32 (2):194-200.
PubMed
6) Fjelstad A, Hommelstad J, Sorteberg A. Infections related to intrathecal baclofen therapy in children and adults:frequency and risk factors. J Neurosurg Pediatr. 2009;4 (5):487-93.
PubMed
7) 水川 克, 近藤 威, 甲村英二. 脳室腹腔シャントを有する患者に対するバクロフェン髄腔内投与療法:3例報告. 脳外誌. 2008;17 (10):794-8.
 
8) Hader WJ, Tellez‐Zenteno J, Metcalfe A, et al. Complications of epilepsy surgery- a systematic review of focal surgical resections and invasive EEG monitoring. Epilepsia. 2013;54 (5):840-7.
 
10) Bellusse CG, Ribeiro JC, De Campos FR, et al. Risk factors for surgical site infection in neurosurgery. Acta Paul Enferm. 2015;28(1):66.
 
11) Cassir N, De La Rosa S, Melot A, et al. Risk factors for surgical site infections after neurosurgery:A focus on the postoperative period. Am J Infect Control. 2015;43 (12):1288-91.
PubMed
P.142 掲載の参考文献
1) 日本化学療法学会/日本外科感染症学会, 術後感染予防抗菌薬ガイドライン作成委員会 編. 術後感染予防抗菌薬適正使用のための実践ガイドライン(追補版). 日化療会誌. 2020;68:310-20.
 
2) 米虫 淳, 小野澤志郎, ほか. CQ7:IVRの施行に関して, どのような衛生管理が必要か? IVR手技施行に関する診療体制についての提言. 日本IVR学会. 2017. 14-9.
 
3) Chambers CE, Eisenhauer MD, McNicol LB, et al. Infection control guidelines for the cardiac catheterization laboratory:society guidelines revisited. Catheter Cardiovasc Interv. 2006;67:78-86.
PubMed
4) O'Grady NP, Alexander M, Burns LA, et al. Guidelines for prevention of intravascular catheter-related infections, 2011. Clin Infect Dis. 2011;2:e162-93.
 
5) Mangram Aj, Horan TC, Pearson ML, et al. Hospital infection control practices committee:guideline for prevention of surgical site infection, 1999. Infect Control Hos Epidemiol. 1999;20:247-80.
 
6) Berrios-Torres SI, Umscheid CA, Bratzler DQ, et al. Centers for disease control and prevention guideline for the prevention of surgical site infection, 2017. JAMA surg. 2017;152:784-91.
 
7) Graves NS, Katsogridakis E, Faris B, et al. Prophylactic antibiotics for percutaneous endovascular procedures. Eur J Clin Microbiol Infect Dis. 2017;36:597-601.
 
8) Chehab MA, Thakor AS, Tulin-Silver S, et al. Adult and pediatric antibiotic prophylaxis during vascular and IR procedures:a society of interventional radiology practice parameter update endorsed by the cardiovascular and interventional radiological society of Europe and the Canadian association for interventional radiology. J Vasc Interv Radiol. 2018;29:1483-501.
PubMed
9) Sutcliffe JA, Briggs JH, Little MW, et al. Antibiotics in interventional radiology. Clin Radiol. 2014;70:223-34.
PubMed
10) Cossu G, Daniel RT, Messerer M. Cerebral abscess after neuro-vascular embolization:own experience and review of the literature. Acta Neurochir (Wien). 2017;159:583-91.
PubMed
11) Shah KA, Katz JM, Dehdashti AR, et al. Cerebral abscess after onyx embolization of an arteriovenous malformation. World Neurosurg. 2020;135:96-9.
PubMed
12) Rao SK, Ahmad O, Tariq F, et al. Cerebral abscess following mechanical thrombectomy for ischemic stroke:report of a case and review of literature. Cureus. 2018;10:e2824.
PubMed

IV章 抗菌薬について

P.153 掲載の参考文献
1) 日本化学療法学会/日本外科感染症学会, 術後感染予防抗菌薬適正使用に関するガイドライン作成委員会 編. 術後感染予防抗菌薬適正使用のための実践ガイドライン. 日本化学療法学会/日本外科感染症学会. 2016.
 
2) 術後感染症予防抗菌薬ガイドライン作成委員会 編. 術後感染予防抗菌薬適正使用のための実践ガイドライン(追補版). 日外感染症会誌. 2020. 17:154-165:2020.
 
3) 細菌性髄膜炎診療ガイドライン2014作成委員会. 細菌性髄膜炎診療ガイドライン2014. 南江堂, 2014.
 
4) 日本医真菌学会侵襲性カンジダ症の診断・治療ガイドライン ガイドライン作成委員会. 日本医真菌学会侵襲性カンジダ症の診断・治療ガイドライン 2013=JSMM Clinical Practice Guidelines for Diagnosis and Treatment of Invasive Candidiasis 2013. 日本医真菌学会, 2013.
 
5) 深在性真菌症のガイドライン作成委員会. 深在性真菌症の診断・治療ガイドライン 2014. 協和企画, 2014.
 
6) Chen K, Wu Y, Wang Q, et al. The methodology and pharmacokinetics study of intraventricular administration of vancomycin in patients with intracranial infections after craniotomy. J Crit Care. 2015;30:1-5.
PubMed
7) LeBras M, Chow I, Mavasa VH, et al. Systematic Review of Efficacy, Pharmacokinetics, and Administration of Intraventricular Aminoglycosides in Adults. Neurocrit Care. 2016;25:492-507.
 
8) Lindeboom JA, Frenken JW, Tuk JG, et al. A randomized prospective controlled trial of antibiotic prophylaxis in intraoral bonegrafting procedures:preoperative single-dose penicillin versus preoperative single-dose clindamycin. Int J Oral Maxillofac Surg. 2006;35:433-6.
PubMed
9) 松村晃寛, 下濱 俊. 中枢神経系真菌感染症の治療動向. 神経治療. 2014;31:18-25.
Medical*Online
10) Lewin JJ 3rd, Cook AM, Gonzales C, et al. Current Practices of Intraventricular Antibiotic Therapy in the Treatment of Meningitis and Ventriculitis:Results from a Multicenter Retrospective Cohort Study. Neurocrit Care. 2019;30:609-16.
PubMed
11) 下枝貞彦, 太田伸. 抗真菌剤最前線. Organ Biology. 2013;20:231-6.
Medical*Online
12) 「てんかん診療ガイドライン」作成委員会. てんかん診療ガイドライン2018. 医学書院, 2018.
 

書評

最近チェックした商品履歴

Loading...